Inhibition of the alternative pathway of complement activation reduces inflammation in experimental autoimmune uveoretinitis-Reference-Cited by-同舟云学术

Inhibition of the alternative pathway of complement activation reduces inflammation in experimental autoimmune uveoretinitis

Published:2010-07-30 Issue:10 Volume:40 Page:2870-2881
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Chen Mei,Muckersie Elizabeth,Luo Chang,Forrester John V.,Xu Heping

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/eji.201040323/fullpdf

Reference48 articles.

1. Complement regulators and inhibitory proteins;Zipfel;Nat. Rev. Immunol.,2009

2. Generation of C5a in the absence of C3: A new complement activation pathway;Huber-Lang;Nat. Med.,2006

3. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins;Sohn;Invest. Ophthalmol. Vis. Sci.,2000

4. Up-regulation of complement factor B in retinal pigment epithelial cells is accompanied by complement activation in the aged retina;Chen;Exp. Eye Res.,2008

5. Para-inflammation in the aging retina;Xu;Prog. Retin. Eye Res.,2009

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VSIG4 ameliorates intestinal inflammation through inhibiting macrophages NLRP3 inflammasome and pyroptosis;Tissue and Cell;2024-02

2. Exploring the involvement of the alternative complement pathway in non-infectious uveitis pathogenesis;Frontiers in Immunology;2023-12-08

3. VSIG4 interaction with heparan sulfates inhibits VSIG4–complement binding;Glycobiology;2023-06-21

4. Therapeutic modulation of V Set and Ig domain-containing 4 (VSIG4) signaling in immune and inflammatory diseases;Cytotherapy;2023-06

5. V-Set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy;Frontiers in Immunology;2022-09-15